<VariationArchive RecordType="classified" VariationID="3065" VariationName="ARSA, 1-BP DEL, 297C" VariationType="Deletion" Accession="VCV000003065" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-07-19" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18104" VariationID="3065">
      <GeneList>
        <Gene Symbol="ARSA" FullName="arylsulfatase A" GeneID="410" HGNC_ID="HGNC:713" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>22q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="50622754" stop="50628152" display_start="50622754" display_stop="50628152" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="51061181" stop="51066600" display_start="51061181" display_stop="51066600" Strand="-" />
          </Location>
          <OMIM>607574</OMIM>
        </Gene>
      </GeneList>
      <Name>ARSA, 1-BP DEL, 297C</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q13.31-qter</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>1-BP DEL, 297C</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="607574.0017" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not provide an HGVS expression for allelic variant 607574.0017 because the paper cited by OMIM describes "deletion of C 447 in exon 2" not "a 1-bp (C) deletion at position 297 of the coding sequence in exon 2".</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="ARSA, 1-BP DEL, 297C AND Metachromatic leukodystrophy" Accession="RCV000003211" Version="3">
        <ClassifiedConditionList TraitSetID="787">
          <ClassifiedCondition DB="MedGen" ID="C0023522">Metachromatic leukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1993-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1993-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8101038</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="787" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5508" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfatide lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral sclerosis diffuse metachromatic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroside sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arylsulfatase A Deficiency</ElementValue>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Metachromatic leukodystrophy</ElementValue>
                <XRef ID="Metachromatic+leukodystrophy/4691" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018868" DB="MONDO" />
                <XRef ID="396338004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MLD</ElementValue>
                <XRef Type="MIM" ID="250100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms. Late-infantile MLD. Onset is before age 30 months. Typical presenting findings include weakness, hypotonia, clumsiness, frequent falls, toe walking, and dysarthria. As the disease progresses, language, cognitive, and gross and fine motor skills regress. Later signs include spasticity, pain, seizures, and compromised vision and hearing. In the final stages, children have tonic spasms, decerebrate posturing, and general unawareness of their surroundings. Juvenile MLD. Onset is between age 30 months and 16 years. Initial manifestations include decline in school performance and emergence of behavioral problems, followed by gait disturbances. Progression is similar to but slower than in the late-infantile form. Adult MLD. Onset occurs after age 16 years, sometimes not until the fourth or fifth decade. Initial signs can include problems in school or job performance, personality changes, emotional lability, or psychosis; in others, neurologic symptoms (weakness and loss of coordination progressing to spasticity and incontinence) or seizures initially predominate. Peripheral neuropathy is common. Disease course is variable – with periods of stability interspersed with periods of decline – and may extend over two to three decades. The final stage is similar to earlier-onset forms.</Attribute>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301309</ID>
                <ID Source="BookShelf">NBK1130</ID>
              </Citation>
              <XRef ID="512" DB="Orphanet" />
              <XRef ID="C0023522" DB="MedGen" />
              <XRef ID="MONDO:0018868" DB="MONDO" />
              <XRef Type="MIM" ID="250100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23369" SubmissionDate="2016-10-11" DateLastUpdated="2016-10-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607574.0017_METACHROMATIC LEUKODYSTROPHY" title="ARSA, 1-BP DEL, 297C_METACHROMATIC LEUKODYSTROPHY" />
        <ClinVarAccession Accession="SCV000023369" DateUpdated="2016-10-14" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In Caucasian patients with metachromatic leukodystrophy (250100), Kreysing et al. (1993) identified a 1-bp (C) deletion at position 297 of the coding sequence in exon 2 of the ARSA gene.</Attribute>
              <Citation>
                <ID Source="PubMed">8101038</ID>
              </Citation>
              <XRef DB="OMIM" ID="250100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSA" />
          </GeneList>
          <Name>ARSA, 1-BP DEL, 297C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 297C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607574.0017" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">METACHROMATIC LEUKODYSTROPHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23369" TraitType="Disease" MappingType="Name" MappingValue="METACHROMATIC LEUKODYSTROPHY" MappingRef="Preferred">
        <MedGen CUI="C0023522" Name="Metachromatic leukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

